Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-α

Cancer Letters

Volumn 128, Issue 1, 1998, Pages 65-70

  Dennis, John U ^a   Dean, Nicholas M ^c   Bennett, C Frank ^c   Griffith, James W ^a   Lang, C Max ^a   Welch, Danny R ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

Antisense; Melanoma metastasis; Oligonucleotide; Protein kinase C

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

ANIMALS; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RNA; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032486223     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00052-4     Document Type: Article

References (35)

1. Nicolson G.L. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim. Biophys. Acta. 695:1982;113-176.
2. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336.
3. Gopalakrishna R., Barsky S.H. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc. Natl. Acad. Sci. USA. 85:1988;612-616.
4. Takenaga K., Takahashi K. Effects of 12-O-tetradecanoylphorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells. Cancer Res. 46:1986;375-380.
5. +2 mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma. Cancer Res. 49:1989;2597-2602.
6. Liu B., Renaud C., Nelson K.K., Chen Y.Q., Bazaz R., Kowynia J., Timar J., Diglio C.A., Honn K.V. Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int. J. Cancer. 52:1992;147-152.
7. Mapelli E., Banfi P., Sala E., Sensi M., Supino R., Zunino F., Gambetta R.A. Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int. J. Cancer. 57:1994;281-286.
8. Blobe G.C., Obeid L.M., Hannun Y.A. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 13:1994;411-431.
9. Dumont J.A., Jones W.D., Bitonti A.J. Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res. 52:1992;1195-1200.
10. Dumont J.A., Bitonti A.J. Modulation of human melanoma cell metastasis and adhesion may involve integrin phosphorylation mediated through protein kinase C. Biochem. Biophys. Res. Commun. 204:1994;264-272.
11. Schwartz G.K., Redwood S.M., Ohnuma T., Holland J.F., Droller M.J., Liu B.C. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J. Natl. Cancer Inst. 82:1990;1753-1756.
12. Hug H., Sarre T.F. Protein kinase C isoenzymes: divergence in signal transduction. Biochem. J. 291:1993;329-343.
13. Bennett D.C., Cooper P.J., Hart I.R. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumor promoter for growth. Int. J. Cancer. 39:1987;414-418.
14. Yamanishi D.T., Graham M., Buckmeier J.A., Meyskens F.L. The differential expression of protein kinase C in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis. 12:1991;105-109.
15. Coppock D.L., Tansey J.B., Scandalis S., Nathanson L. Phorbol esters and growth regulation in metastatic melanoma cells (review). Cancer Treat. Res. 54:1991;67-83.
16. La Porta C.A.M., Comolli R. Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential. Clin. Exp. Metastasis. 15:1997;568-579.
17. Scanlon K.J., Ohta Y., Ishida H., Kijima H., Ohkawa T., Kaminski A., Tsai J., Horng G., Kashani-Sabet M. Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J. 9:1995;1288-1296.
18. Dean N.M., McKay R., Miraglia L., Howard R., Cooper S., Giddings J., Nicklin P., Meister L., Ziel R., Geiger T., Muller M., Fabbro D. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res. 56:1996;3499-3507.
19. Dean N.M., McKay R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA. 91:1994;11762-11766.
20. Crooke S.T. Therapeutic applications of oligonucleotides. BioTechnology. 10:1992;882-886.
21. Dean N.M., McKay R., Condon T.P., Bennett C.F. Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 269:1994;16416-16424.
22. Welch D.R., Bisi J.E., Miller B.E., Conaway D., Seftor E.A., Yohem K.H., Gilmore L.B., Seftor R.E.B., Nakajima M., Hendrix M.J.C. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer. 47:1991;227-237.
23. Welch D.R. Technical considerations for studying cancer metastasis in vivo. Clin. Exp. Metastasis. 15:1997;272-306.
24. Welch D.R., Tomasovic S.P. Implications of tumor progression on clinical oncology. Clin. Exp. Metastasis. 3:1985;151-188.
25. Chiang M.-Y., Chan H., Zounes M.A., Freier S.M., Lima W.F., Bennett C.F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266:1991;18162-18171.
26. Levesque L., Dean N.M., Sasmor H., Crooke S.T. Antisense oligonucleotides targeting human protein kinase C-α inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells. Mol. Pharmacol. 51:1997;209-216.
27. Haller H., Lindschau C., Luft F.C. Role of protein kinase C in intracellular signaling. Ann. N. Y. Acad. Sci. 733:1994;313-324.
28. Vuori K., Ruoslahti E. Activation of protein kinase C precedes α5β1 integrin-mediated cell spreading on fibronectin. J. Biol. Chem. 268:1993;21459-21462.
29. Yamamura S., Nelson P.R., Kent K.C. Role of protein kinase C in attachment, spreading, and migration of human endothelial cells. J. Surg. Res. 63:1996;349-354.
30. Volberg T., Geiger B., Citi S., Bershadsky A.D. Effect of protein kinase inhibitor H-7 on the contractility, integrity, and membrane anchorage of the microfilament system. Cell Motil. Cytoskel. 29:1994;321-338.
31. Liu J.P. Protein kinase C and its substrates. Mol. Cell. Endocrinol. 116:1996;1-29.
32. Pisetsky D.S., Reich C.F. Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci. 54:1993;101-107.
33. Monteith D.K., Henry S.P., Howard R.B., Flournoy S., Levin A.A., Bennett C.F., Crooke S.T. Immune stimulation - a class effect of phosphorothioate oligodeoxynucleotides in rodents. AntiCancer Drug Res. 12:1997;421-432.
34. Stein C.A. Does antisense exist? Nat. Med. 1:1995;1119-1121.
35. Yamamoto T., Yamamoto S., Kataoka T., Tokunaga T. Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Res. Dev. 4:1994;119-122.